STATE STREET CORP - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 139 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$30,600,243
+31.6%
1,761,672
+6.6%
0.00%
+100.0%
Q2 2023$23,259,752
+20.3%
1,651,971
-8.1%
0.00%0.0%
Q1 2023$19,340,497
-56.7%
1,797,444
-39.7%
0.00%0.0%
Q4 2022$44,643,726
+468.7%
2,980,222
+387.5%
0.00%
Q3 2022$7,850,000
+38.5%
611,342
+4.5%
0.00%
Q2 2022$5,667,000
+0.5%
584,831
+3.1%
0.00%
Q1 2022$5,637,000
-67.3%
567,138
-61.3%
0.00%
-100.0%
Q4 2021$17,245,000
-25.6%
1,465,171
-28.0%
0.00%0.0%
Q3 2021$23,168,000
-27.5%
2,034,082
-11.4%
0.00%
-50.0%
Q2 2021$31,965,000
+22.1%
2,294,704
+62.2%
0.00%0.0%
Q1 2021$26,188,000
-6.1%
1,414,782
-10.4%
0.00%0.0%
Q4 2020$27,892,000
+339.3%
1,578,512
+280.9%
0.00%
Q3 2020$6,349,000
-23.1%
414,453
+28.0%
0.00%
-100.0%
Q2 2020$8,252,000
+138.8%
323,880
+45.1%
0.00%
Q1 2020$3,456,000
+38.7%
223,230
-0.9%
0.00%
Q4 2019$2,491,000
+27.5%
225,232
-1.8%
0.00%
Q3 2019$1,953,000
-34.5%
229,477
+4.2%
0.00%
Q2 2019$2,981,000
+30.7%
220,195
+74.4%
0.00%
Q1 2019$2,280,000
-0.7%
126,223
+54.5%
0.00%
Q4 2018$2,296,000
+39.5%
81,724
+26.7%
0.00%
Q3 2018$1,646,00064,4990.00%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Spearhead Capital Advisors, LLC 202,580$2,601,0002.82%
Lion Point Capital, LP 480,000$5,140,0001.13%
HHLR ADVISORS, LTD. 2,920,023$37,493,0000.99%
TANG CAPITAL MANAGEMENT LLC 600,000$7,704,0000.94%
Rubric Capital Management LP 1,446,107$18,568,0000.94%
AlphaCentric Advisors LLC 43,000$552,0000.57%
RICE HALL JAMES & ASSOCIATES, LLC 749,933$9,629,0000.56%
Parkman Healthcare Partners LLC 126,192$1,620,0000.46%
Birchview Capital, LP 30,000$385,0000.27%
Baker Brothers Advisors 2,799,577$35,947,0000.24%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders